DE FOUGEROLLES, Antonin,DIENER, John L.,HICKMAN, Emma,HINKLE, Gregory,MILSTEIN, Stuart,PULICHINO, Anne-Marie,SPRAGUE, Andrew
申请号：
AU2017201838
公开号：
AU2017201838A1
申请日:
2017.03.17
申请国别(地区):
AU
年份:
2017
代理人:
摘要：
#$%^&*AU2017201838A120170406.pdf#####Abstract The present disclosure relates to RNAi agents useful in methods of treating BetaENaC-related diseases such as cystic fibrosis, pseudohypoaldosteronism type I (PHA1), Liddles syndrome, hypertension, alkalosis, hypokalemia, and obesity-associated hypertension, using a therapeutically effective amount of a RNAi agent to Beta-ENaC.
